Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
    November 2017
  1. ZHANG J, Raju GS, Chang DW, Lin SH, et al
    Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31062.
    >> Share

    October 2017
    Some stage III colon cancer patients may need only half of the standard chemotherapy course.
    Cancer. 2017;123:3871.
    >> Share

  3. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    >> Share

  4. LEVI Z, Kark JD, Katz LH, Twig G, et al
    Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population-based study.
    Cancer. 2017;123:4022-4030.
    >> Share

  5. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    >> Share

  6. SEGNAN N, Armaroli P
    Early detection versus prevention in colorectal cancer screening: Methods estimates and public health implications.
    Cancer. 2017 Oct 4. doi: 10.1002/cncr.31032.
    >> Share

  7. HONG YR, Tauscher J, Cardel M
    Distrust in health care and cultural factors are associated with uptake of colorectal cancer screening in Hispanic and Asian Americans.
    Cancer. 2017 Oct 4. doi: 10.1002/cncr.31052.
    >> Share

    September 2017
  8. CESPEDES FELICIANO EM, Lee VS, Prado CM, Meyerhardt JA, et al
    Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.
    Cancer. 2017 Sep 7. doi: 10.1002/cncr.30950.
    >> Share

  9. SADETZKI S, Chetrit A, Freedman LS, Hakak N, et al
    Cancer risk among Holocaust survivors in Israel-A nationwide study.
    Cancer. 2017;123:3335-3345.
    >> Share

    August 2017
  10. KOCARNIK JM, Hua X, Hardikar S, Robinson J, et al
    Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: The Colon Cancer Family Registry.
    Cancer. 2017 Aug 25. doi: 10.1002/cncr.30932.
    >> Share

  11. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
    Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Cancer. 2017;123:3116-3124.
    >> Share

  12. PRINTZ C
    Sulfide-producing bacteria linked to higher colon cancer risk in African Americans.
    Cancer. 2017;123:2795.
    >> Share

  13. JAGAI JS, Messer LC, Rappazzo KM, Gray CL, et al
    County-level cumulative environmental quality associated with cancer incidence.
    Cancer. 2017;123:2901-2908.
    >> Share

  14. MALAPELLE U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, et al
    Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
    Cancer. 2017;125:615-626.
    >> Share

    July 2017
  15. GREEN BB, Anderson ML, Cook AJ, Chubak J, et al
    A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.
    Cancer. 2017 Jul 28. doi: 10.1002/cncr.30908.
    >> Share

  16. PRINTZ C
    Physicians discuss genetic testing for and treatment of colorectal cancer.
    Cancer. 2017;123:2591-2593.
    >> Share

  17. LIN SC, McKinley D, Sripipatana A, Makaroff L, et al
    Colorectal cancer screening at US community health centers: Examination of sociodemographic disparities and association with patient-provider communication.
    Cancer. 2017 Jul 14. doi: 10.1002/cncr.30855.
    >> Share

  18. OKAZAKI S, Schirripa M, Loupakis F, Cao S, et al
    Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
    Cancer. 2017 Jul 14. doi: 10.1002/cncr.30880.
    >> Share

  19. SHARP L, McDevitt J, Brown C, Carsin AE, et al
    Association between smoking at diagnosis and cause-specific survival in patients with rectal cancer: Results from a population-based analysis of 10,794 cases.
    Cancer. 2017;123:2543-2550.
    >> Share

  20. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    >> Share

    June 2017
  21. RICKER CN, Hanna DL, Peng C, Nguyen NT, et al
    DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30790.
    >> Share

  22. LONG Y, Sanchez-Espiridion B, Lin M, White L, et al
    Global and targeted serum metabolic profiling of colorectal cancer progression.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30829.
    >> Share

  23. HILLYER GC, Jensen CD, Zhao WK, Neugut AI, et al
    Primary care visit use after positive fecal immunochemical test for colorectal cancer screening.
    Cancer. 2017 Jun 16. doi: 10.1002/cncr.30809.
    >> Share

    May 2017
  24. LEE DW, Han SW, Cha Y, Bae JM, et al
    Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
    Cancer. 2017 May 17. doi: 10.1002/cncr.30760.
    >> Share

  25. PARTIN MR, Gravely AA, Burgess JF Jr, Haggstrom DA, et al
    Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Cancer. 2017 May 11. doi: 10.1002/cncr.30765.
    >> Share

  26. RICE K, Gressard L, DeGroff A, Gersten J, et al
    Increasing colonoscopy screening in disparate populations: Results from an evaluation of patient navigation in the New Hampshire Colorectal Cancer Screening Program.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30761.
    >> Share

  27. LUDMIR EB, Palta M, Willett CG, Czito BG, et al
    Total neoadjuvant therapy for rectal cancer: An emerging option.
    Cancer. 2017;123:1497-1506.
    >> Share

  28. SUN Z, Ke X, Salzberg SL, Kim D, et al
    The novel fusion transcript NR5A2-KLHL29FT is generated by an insertion at the KLHL29 locus.
    Cancer. 2017;123:1507-1515.
    >> Share

  29. COOPER GS, Kou TD, Dor A, Koroukian SM, et al
    Cancer preventive services, socioeconomic status, and the Affordable Care Act.
    Cancer. 2017;123:1585-1589.
    >> Share

    April 2017
  30. JO AM, Nguyen TT, Stewart S, Sung MJ, et al
    Lay health educators and print materials for the promotion of colorectal cancer screening among Korean Americans: A randomized comparative effectiveness study.
    Cancer. 2017 Apr 25. doi: 10.1002/cncr.30568.
    >> Share

  31. MOWERY YM, Salama JK, Zafar SY, Moore HG, et al
    Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
    Cancer. 2017;123:1434-1441.
    >> Share

  32. BLACK DS, Peng C, Sleight AG, Nguyen N, et al
    Mindfulness practice reduces cortisol blunting during chemotherapy: A randomized controlled study of colorectal cancer patients.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30698.
    >> Share

    March 2017
  33. MERCHANT SJ, Nanji S, Brennan K, Karim S, et al
    Management of stage III colon cancer in the elderly: Practice patterns and outcomes in the general population.
    Cancer. 2017 Mar 27. doi: 10.1002/cncr.30691.
    >> Share

  34. CASSIDY RJ, Liu Y, Patel K, Zhong J, et al
    Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.
    Cancer. 2017;123:783-793.
    >> Share

    February 2017
  35. SEHDEV A, Sherer EA, Hui SL, Wu J, et al
    Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.
    Cancer. 2017 Feb 17. doi: 10.1002/cncr.30569.
    >> Share

  36. FRANKEL TL, Vakiani E, Nathan H, DeMatteo RP, et al
    Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases.
    Cancer. 2017;123:568-575.
    >> Share

  37. SAHLMANN CO, Homayounfar K, Niessner M, Dyczkowski J, et al
    Repeated adjuvant anti-CEA radioimmunotherapy after resection of colorectal liver metastases: Safety, feasibility, and long-term efficacy results of a prospective phase 2 study.
    Cancer. 2017;123:638-649.
    >> Share

  38. REDDY SK, Boland PM, Nurkin SJ
    Primary tumor resection does not improve survival among patients with unresectable colorectal cancer metastases-But who determines resectability?
    Cancer. 2017 Feb 8. doi: 10.1002/cncr.30595.
    >> Share

    January 2017
  39. YANG B, Gapstur SM, Newton CC, Jacobs EJ, et al
    Alcohol intake and mortality among survivors of colorectal cancer: The Cancer Prevention Study II Nutrition Cohort.
    Cancer. 2017 Jan 30. doi: 10.1002/cncr.30556.
    >> Share

  40. BARZI A, Lenz HJ, Quinn DI, Sadeghi S, et al
    Comparative effectiveness of screening strategies for colorectal cancer.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30518.
    >> Share

  41. HSU T, Speers CH, Kennecke HF, Cheung WY, et al
    The utility of abbreviated patient-reported outcomes for predicting survival in early stage colorectal cancer.
    Cancer. 2017 Jan 12. doi: 10.1002/cncr.30511.
    >> Share

  42. XU Z, Mohile SG, Tejani MA, Becerra AZ, et al
    Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
    Cancer. 2017;123:52-61.
    >> Share

  43. AMINI A, Jones BL, Ghosh D, Schefter TE, et al
    Impact of facility volume on outcomes in patients with squamous cell carcinoma of the anal canal: Analysis of the National Cancer Data Base.
    Cancer. 2017;123:228-236.
    >> Share

    December 2016
  44. HOFFMAN AS, Lowenstein LM, Kamath GR, Housten AJ, et al
    An entertainment-education colorectal cancer screening decision aid for African American patients: A randomized controlled trial.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30489.
    >> Share

  45. MULLER CJ, Robinson RF, Smith JJ, Jernigan MA, et al
    Text message reminders increased colorectal cancer screening in a randomized trial with Alaska Native and American Indian people.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30499.
    >> Share

  46. DAVIS SN, Christy SM, Chavarria EA, Abdulla R, et al
    A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30481.
    >> Share

  47. GULATI R, Albertsen PC
    Insights from the PLCO trial about prostate cancer screening.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30472.
    >> Share

    November 2016
  48. GANESH K, Shah RH, Vakiani E, Nash GM, et al
    Clinical and genetic determinants of ovarian metastases from colorectal cancer.
    Cancer. 2016 Nov 22. doi: 10.1002/cncr.30424.
    >> Share

  49. PHIPPS AI, Robinson JR, Campbell PT, Win AK, et al
    Prediagnostic alcohol consumption and colorectal cancer survival: The Colon Cancer Family Registry.
    Cancer. 2016 Nov 8. doi: 10.1002/cncr.30446.
    >> Share

    September 2016
  50. DURCINOSKA I, Young JM, Solomon MJ
    Patterns and predictors of colorectal cancer care coordination: A population-based survey of Australian patients.
    Cancer. 2016 Sep 7. doi: 10.1002/cncr.30326.
    >> Share

    August 2016
  51. TONG EK, Nguyen TT, Lo P, Stewart SL, et al
    Lay health educators increase colorectal cancer screening among Hmong Americans: A cluster randomized controlled trial.
    Cancer. 2016 Aug 26. doi: 10.1002/cncr.30265.
    >> Share

  52. ALAWADI Z, Phatak UR, Hu CY, Bailey CE, et al
    Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer.
    Cancer. 2016 Aug 1. doi: 10.1002/cncr.30230.
    >> Share

    July 2016
  53. CHRISTY SM, Davis SN, Williams KR, Zhao X, et al
    A community-based trial of educational interventions with fecal immunochemical tests for colorectal cancer screening uptake among blacks in community settings.
    Cancer. 2016 Jul 15. doi: 10.1002/cncr.30207.
    >> Share

  54. CASADABAN L, Rauscher G, Aklilu M, Villenes D, et al
    Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Cancer. 2016 Jul 15. doi: 10.1002/cncr.30181.
    >> Share

  55. VIJAYVERGIA N, Li T, Wong YN, Hall MJ, et al
    Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer.
    Cancer. 2016 Jul 5. doi: 10.1002/cncr.30077.
    >> Share

    June 2016
  56. LOWERY JT, Ahnen DJ, Schroy PC 3rd, Hampel H, et al
    Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.
    Cancer. 2016 Jun 3. doi: 10.1002/cncr.30080.
    >> Share

  57. ERENAY FS, Alagoz O, Banerjee R, Said A, et al
    Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.
    Cancer. 2016 Jun 1. doi: 10.1002/cncr.30091.
    >> Share

  58. VAN DER MEULEN MP, Lansdorp-Vogelaar I, van Heijningen EM, Kuipers EJ, et al
    Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness-A modeling study.
    Cancer. 2016;122:1680-8.
    >> Share

  59. WANG M, Aldubayan S, Connor AA, Wong B, et al
    Genetic testing for Lynch syndrome in the province of Ontario.
    Cancer. 2016;122:1672-9.
    >> Share

  60. WEISS J, Grilley Olson J, Deal AM, Chera B, et al
    Using the galactose-alpha-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximab.
    Cancer. 2016;122:1697-701.
    >> Share

    May 2016
  61. LADABAUM U, Patel A, Mannalithara A, Sundaram V, et al
    Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool.
    Cancer. 2016 May 24. doi: 10.1002/cncr.30096.
    >> Share

  62. JOSEPH DA, Meester RG, Zauber AG, Manninen DL, et al
    Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity.
    Cancer. 2016 May 20. doi: 10.1002/cncr.30070.
    >> Share

    April 2016
  63. AL MOUSTAFA AE, Al-Antary NT
    Specific gene patterns and molecular pathways related to human carcinogenesis in different populations among various geographic locations.
    Cancer. 2016;122:1134-5.
    >> Share

  64. SIRAJ AK, Beg S, Al-Kuraya KS
    Reply to specific gene patterns and molecular pathways related to human carcinogenesis in different populations among various geographic locations.
    Cancer. 2016;122:1135-7.
    >> Share

    March 2016
  65. MOR V, Joyce NR, Cote DL, Gidwani RA, et al
    The rise of concurrent care for veterans with advanced cancer at the end of life.
    Cancer. 2016;122:782-90.
    >> Share

  66. WRIGHT BJ, Conlin AK, Allen HL, Tsui J, et al
    What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage.
    Cancer. 2016;122:791-7.
    >> Share

    February 2016
  67. CORDERO-MORALES A, Savitzky MJ, Stenning-Persivale K, Segura ER, et al
    Conceptual considerations and methodological recommendations for the use of the mortality-to-incidence ratio in time-lagged, ecological-level analysis for public health systems-oriented cancer research.
    Cancer. 2016;122:486-7.
    >> Share

  68. SUNKARA V, Hebert JR
    The application of the mortality-to-incidence ratio for the evaluation of cancer care disparities globally.
    Cancer. 2016;122:487-8.
    >> Share

  69. TEVAARWERK AJ, Lee JW, Terhaar A, Sesto ME, et al
    Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study.
    Cancer. 2016;122:438-46.
    >> Share

  70. STOVER AM, Basch EM
    Using patient-reported outcome measures as quality indicators in routine cancer care.
    Cancer. 2016;122:355-7.
    >> Share

  71. SMITH TG, Castro KM, Troeschel AN, Arora NK, et al
    The rationale for patient-reported outcomes surveillance in cancer and a reproducible method for achieving it.
    Cancer. 2016;122:344-51.
    >> Share

    January 2016
  72. LITZELMAN K, Kent EE, Rowland JH
    Social factors in informal cancer caregivers: The interrelationships among social stressors, relationship quality, and family functioning in the CanCORS data set.
    Cancer. 2016;122:278-86.
    >> Share

  73. TOROK JA, Palta M, Willett CG, Czito BG, et al
    Nonoperative management of rectal cancer.
    Cancer. 2016;122:34-41.
    >> Share

    November 2015
  74. NYROP KA, Deal AM, Williams GR, Guerard EJ, et al
    Physical activity communication between oncology providers and patients with early-stage breast, colon, or prostate cancer.
    Cancer. 2015 Nov 13. doi: 10.1002/cncr.29786.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016